BISU News Bio-Solutions Corp Begins Production

SAN ANTONIO, July 30, 2012 /PRNewswire/ -- (OTCQB: BISU) (PINKSHEETS: BISU) Bio-Solutions Corp is pleased to announce that the company has started production of the recently acquired Type2 Defense™. Type2 Defense™ is an Antioxidant and glucose control dietary supplement powder. This proprietary formula is packaged with 30 packets to a box. The product powder drink mix delivery system has been developed to support healthy glucose levels for type 2 diabetics and pre-diabetics. From a "Target Market" perspective, management believes this to be a very lucrative market place that has a built in clientele here domestically in North America to drive sales and revenues. Type2 Defense™ has been scheduled for Market entry by September 2012. "We will be completing the first production run of Type2 Defense™ very soon. We are excited about our new product, which will be sold and marketed primarily on the internet, further company developments, forthcoming," stated newly appointed CEO Bill Gallagher.

There is an Estimated 100 plus Million Americans at risk of diabetes in the following order: Data from the 2011 National Diabetes Fact Sheet (released Jan. 26, 2011) Total prevalence of diabetes Total: 25.8 million children and adults in the United States -- 8.3% of the population -- have diabetes. Diagnosed: 18.8 million people Undiagnosed: 7.0 million people Pre-diabetes: 79 million people

New Cases: 1.9 million new cases of diabetes are diagnosed in people aged 20 years and older in 2010.

In contrast to the 2007 National Diabetes Fact Sheet, which used fasting glucose data to estimate undiagnosed diabetes and pre-diabetes, the 2011 National Diabetes Fact Sheet uses both fasting glucose and A1C levels to derive estimates for undiagnosed diabetes and pre-diabetes. These tests were chosen because they are most frequently used in clinical practice.